One other increasingly important collaborator in translational research is the HKU-Shenzhen Hospital. The hospital celebrated its 10th anniversary last year after a remarkable decade: National 3A Hospital Accreditation, National Standardised Resident Training Base, Teaching Hospital for General Medical Colleges in Guangdong Province, and lead in more than 300 nationally-funded research programmes, among other achievements. HKU has signed a second 10-year collaborative agreement with the Shenzhen Municipal People’s Government to continue to provide first-class clinical service, education and administration at the hospital to support its aspirations to ever-higher standards. In addition – and this relates to our research – the hospital will act as an innovative research platform and incubation centre. It will provide Phase 1, 2 and 3 clinical trials and connect with industry to help translate innovations into applications. This will allow us to expand our research opportunities and contribute to the development of healthcare and biomedicine in the GBA in the coming decade. Of course, we also want to contribute to the development of healthcare within Hong Kong. A major event this year has been the government’s blueprint for providing more and better primary care. This has not only prompted a rethink of our curricula but inspired the launch of the HKU Primary Healthcare Initiative in our Faculty to conduct multidisciplinary research, training, evaluation and policy advocacy and innovation. It is led by Professor Sophia Chan Siu-chee, the former Secretary for Food and Health who initiated the government’s Primary Healthcare Blueprint, so I am confident it will play a major role in advancing primary healthcare in Hong Kong. 29
RkJQdWJsaXNoZXIy Mzg4NDg0